bca-101
biocon,bicara therapeutics
['bca101 ']
#bicaratherapeutics presents data from dose escalation portion of ongoing phase 1/1b trial of lead #bifunctional program, #bca101 at the #asco22 
Follow top-line development in the oncology commercial domain. Gain entry to KOL discussions, including both medical professionals and business leaders.